scholarly journals Risk Factor Management with Guideline-Based Medications for Prevention of Recurrent Ischemic Stroke: A Retrospective Chart Review

2017 ◽  
Vol 8 (4) ◽  
pp. 5
Author(s):  
Jessica S. Rose ◽  
Jeffrey A. Kyle ◽  
Jessica W. Skellley
Keyword(s):  
Transient Ischemic Attack ◽  
Stroke Prevention ◽  
Chart Review ◽  
Recurrent Stroke ◽  
Retrospective Chart Review ◽  
Cardioembolic Stroke ◽  
Secondary Stroke Prevention ◽  
Number Of Patients ◽  
Appropriate Prescribing ◽  
Ischemic Attack

Background: Implementation of new practice guidelines for stroke prevention has decreased the number of patients experiencing recurrent stroke. Clinical trials show antihypertensives, high-intensity statins, and antithrombotics to be beneficial after stroke. Objective: The objective of this study was to determine if recurrent stroke patients were discharged on guideline-based medications for secondary stroke prevention, and to identify potential errors in appropriate prescribing of medications. Methods: A retrospective chart review was conducted at a community hospital and included patients 19 years and older diagnosed with their second, third, or fourth stroke (transient ischemic attack or cerebrovascular accident). Descriptive statistics were used to describe collected information. Collected data included relevant patient demographics, diagnosis, past medical history, medications, and readmission rates. The primary objective was the percentage of patients appropriately discharged on guideline-based secondary stroke prevention medications. Appropriate treatment was based upon the 2010 and 2014 American Heart Association/American Stroke Association Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. Results: A total of 124 charts were reviewed, 106 charts met the inclusion criteria. Guideline-based and appropriate medication-use was initiated in 9% and 4% of patients with noncardioembolic and cardioembolic stroke, respectively. Therapy deemed not guideline-based, but appropriate was initiated in 20% and 9% of patients with noncardioembolic and cardioembolic stroke, respectively. Errors in appropriate prescribing of secondary prevention medications were related to statins and antihypertensives. Conclusion: Better adherence to preventative recurrent stroke measures is needed at the time of patient discharge.   Type: Student Project

scholarly journals Antithrombotic Prescription at Discharge in Medicare Patients with Ischemic Stroke/Transient Ischemic Attack: Results from the National Stroke Project

Stroke ◽  
2001 ◽  
Vol 32 (suppl_1) ◽  
pp. 376-377
Author(s):  
Timothy F Kresowik ◽  
David S Nilasena ◽  
Anton F Piskac ◽  
Rebecca A Hemann ◽  
Marian A Brenton ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Transient Ischemic Attack ◽  
Stroke Prevention ◽  
Antiplatelet Agents ◽  
Secondary Stroke Prevention ◽  
Antithrombotic Agents ◽  
Patterns Of Use ◽  
Medicare Patients ◽  
Ischemic Attack ◽  
Univariate Analyses

P205 Background: Antiplatelet agents have been shown to be effective for secondary stroke prevention in patients with ischemic stroke (IS) or transient ischemic attack (TIA). As part of HCFA’s National Stroke Project, we examined patterns of use of antithrombotic agents for inpatients with IS or TIA. Methods: Findings were based on abstracted data from a sample of Medicare inpatient medical records (discharge dates 4/98 - 3/99). All U.S. states, the District of Columbia and Puerto Rico were sampled using a systematic random approach. Each record had a principal diagnosis of one of the following ICD-9-CM codes: 362.34, 433.xx, 434.xx, 435.0, 435.1, 435.3, 435.8, 435.9 or 436. The main outcome measure was the frequency of eligible patients with a prescription or a plan for antithrombotic therapy at discharge. Antithrombotics were aspirin, clopidogrel, dipyridamole, ticlopidine and warfarin. Results: Of the 36,650 cases reviewed, 25,659 met the criteria for inclusion in the indicator. A large percentage of excluded cases (53.1%) were removed due to a history or current finding of hemorrhage. Nationwide, 20,947 (unadjusted rate 81.6%) patients were prescribed an antithrombotic at discharge or had a plan for starting an antithrombotic after discharge. The state-specific rates ranged from 72.0% to 90.1%. Univariate analyses showed this therapy was prescribed less frequently (p<0.001) for adults 85 years and over (rate=77.8%, OR=0.74, 95% CI=0.69–0.80), women (rate=80.4%, OR=0.83, 95% CI=0.78–0.89) and African-Americans (rate=77.6%, OR=0.76, 95% CI=0.68–0.85). Asians were found to have been prescribed this therapy more frequently than other races (p<0.02, rate=87.2%, OR=1.54 95% CI=1.10–2.16). Among those IS/TIA patients who also had atrial fibrillation (AF), 57.1% received warfarin. Conclusions: Antithrombotic agents are not prescribed for almost one-fifth of eligible Medicare inpatients with IS/TIA. For those with IS/TIA and AF, a large proportion are not treated with warfarin. These results show important opportunities for improvement in secondary stroke prevention for Medicare patients.

scholarly journals Participants’ Perspective of Engaging in a Gym-Based Health Service Delivered Secondary Stroke Prevention Program after TIA or Mild Stroke

2021 ◽  
Vol 18 (21) ◽  
pp. 11448
Author(s):  
Maria Sammut ◽  
Kirsti Haracz ◽  
Coralie English ◽  
David Shakespeare ◽  
Gary Crowfoot ◽  
...  
Keyword(s):  
Health Service ◽  
Prevention Program ◽  
Stroke Prevention ◽  
Recurrent Stroke ◽  
Constructivist Grounded Theory ◽  
Secondary Stroke Prevention ◽  
Structured Interviews ◽  
Community Based ◽  
Mild Stroke ◽  
Ischemic Attack

People who have had a transient ischemic attack (TIA) or mild stroke have a high risk of recurrent stroke. Secondary prevention programs providing support for meeting physical activity recommendations may reduce this risk. Most evidence for the feasibility and effectiveness of secondary stroke prevention arises from programs developed and tested in research institute settings with limited evidence for the acceptability of programs in ‘real world’ community settings. This qualitative descriptive study explored perceptions of participation in a secondary stroke prevention program (delivered by a community-based multidisciplinary health service team within a community gym) by adults with TIA or mild stroke. Data gathered via phone-based semi-structured interviews midway through the program, and at the end of the program, were analyzed using constructivist grounded theory methods. A total of 51 interviews from 30 participants produced two concepts. The first concept, “What it offered me”, describes critical elements that shape participants’ experience of the program. The second concept, “What I got out of it” describes perceived benefits of program participation. Participants perceived that experiences with peers in a health professional-led group program, held within a community-based gym, supported their goal of changing behaviour. Including these elements during the development of health service strategies to reduce recurrent stroke risk may strengthen program acceptability and subsequent effectiveness.

scholarly journals ADHERENCE TO SECONDARY STROKE PREVENTION THERAPIES IN ISCHEMIC STROKE PATIENTS AT TEACHING HOSPITAL IN CENTRAL JAVA INDONESIA

2017 ◽  
Vol 10 (14) ◽  
pp. 28 ◽  
Author(s):  
Hidayah Karuniawati ◽  
Zullies Ikawati ◽  
Abdul Gofir
Keyword(s):  
Teaching Hospital ◽  
Stroke Prevention ◽  
Quantitative Research ◽  
Recurrent Stroke ◽  
Heart Association ◽  
Lipid Lowering ◽  
Secondary Stroke Prevention ◽  
Central Java ◽  
Number Of Patients ◽  
High Adherence

Objective: Patients who survive from the first stroke have risk factors to be recurrent. Based on American Heart Association/American Stroke Association and PERDOSSI (Indonesian Neurologist Association), medications which are prescribed to reduce the risk of recurrent stroke as secondary stroke prevention therapies include antiplatelet/anticoagulant as well as antihypertensive and lipid lowering agent. Patients’ adherence to the secondary stroke prevention therapies is important to reduce the recurrent stroke. Methods: This is a quantitative research and the data was collected retrospectively. The number of subjects of this study were 165 respondents. The participants were interviewed by researchers about their adherence to secondary stroke prevention by Modified Morisky Adherence Scale 8 (MMAS-8) questionnaire. Patients’ adherence was stated as low (MMAS-8 score < 6); moderate (MMAS-8 score = 6-7) and high (MMAS-8 = 8). This research was taken at a teaching hospital in Central Java Indonesia.Results: Of 165 participants, 48 participants (29%) were categorized to have low adherence, 43 participants (26%) had moderate adherence, and 74 participants (45%) had high adherence to secondary stroke prevention therapies. The reasons for not adhering to the medications were felt better (34.1%), forgetfulness (18.7%), boredom (16.5%), lack of family support (8.8%), lack of time (6.6%), felt worse (5.5%), concern about side effects (3.3%), preference to Complementary Alternative Medicines (3.3%), and cost (3.3%).Conclusion: The number of patients who has high adherence to secondary stroke prevention was 45% and the most common reason why participants did not adhere to therapy was because they felt better (34.1%).   

Abstract 2739: Cardioembolic Stroke Is Frequent in the Late Recurrence After Transient Ischemic Attack

Stroke ◽  
2012 ◽  
Vol 43 (suppl_1) ◽  
Author(s):  
Takao Hoshino ◽  
Takehiko Nagao ◽  
Satoko Mizuno ◽  
Satoru Shimizu ◽  
Shinichiro Uchiyama
Keyword(s):  
Transient Ischemic Attack ◽  
Clinical Characteristics ◽  
Recurrent Stroke ◽  
Late Recurrence ◽  
Early Recurrence ◽  
Cardioembolic Stroke ◽  
Stroke Patients ◽  
Ischemic Attack ◽  
Recurrence Group ◽  
Group 1

Background The high risk of stroke after transient ischemic attack (TIA) has been widely recognized, although the differences of clinical characteristics between early and late recurrent stroke were not well-known. Materials and methods The subjects were 133 consecutive ischemic stroke patients who were admitted to our hospital within one week of onset, and had previously diagnosed as “definite TIA” by trained stroke neurologists. They were divided into five groups according to the interval between prior TIA and subsequent stroke; (1) within 48 hours, (2) 48 hours to 1 week, (3) 1 week to 1 month, (4) 1 month to 3 months, and (5) after 3 months (group 1 to 5, respectively). Then, we compared clinical characteristics and prognosis between the patients who presented recurrent stroke within and after 1 week subsequent to TIA (early recurrence group and late recurrence group, respectively). Results Of the 133 acute stroke patients (mean age 69.9 years, male 66.9%), 46 (34.9%) were in group 1, 28 (21.2%) in group 2, 23 (17.4%) in group 3, 18 (13.6%) in group 4, and 17 (12.9%) in group 5. As to stroke subtypes, most of the non-cardioembolic strokes were frequently observed shortly after TIA, while the percentage of cardioembolism remained high even the time from prior TIA passed ( Figure ). The prevalence of atrial fibrillation (Af) was higher (39.7% vs. 21.3%, P =0.034), and dyslipidemia was lower (41.4% vs. 64.0%, P =0.014) in the late recurrence group than in the early recurrence group. The percentages of patients with hypertension, diabetes mellitus, and higher ABCD 2 score (≥3 or ≥5) were similar in both groups. Among 42 patients with Af, 14 (33.3%) were premorbid, 16 (38.1%) were diagnosed when TIA presented, and 12(28.6%) were diagnosed when stroke presented. In the late recurrence group, 37/58 patients (63.8%) had a poor outcome (modified Rankin Scale ≥3) at 3 month of stroke onset, significantly higher than the 29/75 (38.7%) patients in the early recurrence group ( P =0.005). Conclusions The frequency of cardioembolic stroke dose not decline during the time course after TIA, while most of the non-cardioembolic stroke recur early after TIA. This might be responsible for the poorer functional outcome in late recurrent stroke. More than quarter of Af patients had been asymptomatic before stroke, which suggests the need for repeated examinations to detect Af in patients with TIA of unknown etiology.

2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack

2017 ◽  
Vol 12 (3) ◽  
pp. 302-320 ◽  
Author(s):  
Yongjun Wang ◽  
Ming Liu ◽  
Chuanqiang Pu
Keyword(s):  
Ischemic Stroke ◽  
Secondary Prevention ◽  
Transient Ischemic Attack ◽  
Recurrent Stroke ◽  
Stroke Recurrence ◽  
Evidence Based ◽  
Cerebrovascular Disorder ◽  
Level Of Evidence ◽  
Vascular Stenosis ◽  
Ischemic Attack

Ischemic stroke and transient ischemic attack (TIA) are the most common cerebrovascular disorder and leading cause of death in China. The Effective secondary prevention is the vital strategy for reducing stroke recurrence. The aim of this guideline is to provide the most updated evidence-based recommendation to clinical physicians from the prior version. Control of risk factors, intervention for vascular stenosis/occlusion, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke are all recommended, and the prevention of recurrent stroke in a variety of uncommon causes and subtype provided as well. We modified the level of evidence and recommendation according to part of results from domestic RCT in order to facility the clinical practice.

Sign in / Sign up

Export Citation Format

Share Document